跳至主要内容
临床试验/NL-OMON46303
NL-OMON46303尚未招募2 期

Inhibition of salivary glands to reduce uptake of radioactive Iodine - Inhibition of Salivary glands for radioactive Iodine

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - In follow-up after treatment for thyroid carcinoma
  • - Received only one treatment with Iodine-131
  • - Currently no signs of recurrence

排除标准

  • - Age < 18y
  • - Inability to provide informed consent
  • - Planned changes in treatment/medication between the baseline scan and intervention scan
  • - History of disease or treatment involving the salivary glands (Malignant or benign tumour, sialoadenitis, stone, surgery, SLE, RT to head-neck, etc)
  • - Currently on anticholinergic medication
  • - Contra-indications for anticholinergic medication (Glaucoma, obstructed digestive/urological tract, megacolon, ileus, tardive dyskinesia)

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Inhibition of salivary glands to reduce uptake of... | 临床试验